| Literature DB >> 19930542 |
Imke E Mulder1, Bettina Schmidt, Christopher R Stokes, Marie Lewis, Mick Bailey, Rustam I Aminov, James I Prosser, Bhupinder P Gill, John R Pluske, Claus-Dieter Mayer, Corran C Musk, Denise Kelly.
Abstract
BACKGROUND: Early microbial colonization of the gut reduces the incidence of infectious, inflammatory and autoimmune diseases. Recent population studies reveal that childhood hygiene is a significant risk factor for development of inflammatory bowel disease, thereby reinforcing the hygiene hypothesis and the potential importance of microbial colonization during early life. The extent to which early-life environment impacts on microbial diversity of the adult gut and subsequent immune processes has not been comprehensively investigated thus far. We addressed this important question using the pig as a model to evaluate the impact of early-life environment on microbe/host gut interactions during development.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19930542 PMCID: PMC2785767 DOI: 10.1186/1741-7007-7-79
Source DB: PubMed Journal: BMC Biol ISSN: 1741-7007 Impact factor: 7.431
Indices of diversity, richness and library coverage for 16S rRNA gene libraries.
| Measurement | IN | OUT | IR |
|---|---|---|---|
| 995 | 734 | 780 | |
| 259.02 | 254.89 | 302.53 | |
| 4.438 | 4.190 | 4.355 | |
| 0.980 | 0.975 | 0.979 | |
| 52.00 | 40.41 | 47.47 | |
| 93.47 | 92.46 | 90.97 | |
Calculations were made based on OTU definition at 99% sequence identity (N = 4).
Figure 1Treatment-based rarefaction curves of 16S rRNA gene libraries. The rarefaction curves from IN (pink), OUT (green) and IR (black) animals were generated by plotting the number of phylotypes (OTUs; defined at 99% sequence identity) against the number of clones sequenced. The shape of the curves of observed phylotype richness indicates a trend of diminishing chance of finding new phylotypes as sampling continues.
Figure 2Collector's curves of the observed and estimated phylotype richness of 16S rRNA gene libraries. Collector's curves of the observed (blue) and estimated (ACE (pink) and Chao1 (yellow)) phylotype richness calculated for IN (A), OUT (B) and IR (C) at 99% level. Each curve reflects observed or estimated richness values obtained as more clones are added to the data set. After an initial steep rise, the curves level out suggesting that a majority of clones in the treatment groups have been sampled. Differences between the estimates and observed phylotype richness were highest in the IR group. Novel phylotypes continued to be identified up to the end of sampling in this group.
Figure 3Phylogenetic distribution of clones obtained from mucosa-adherent ileal and fecal samples in different housing environments. The majority of clones were assigned to the phyla Firmicutes, Proteobacteria, Bacteroidetes, and Actinobacteria. The Firmicutes phylum was significantly increased in the OUT group compared to the IR group (P < 0.05). The Bacteroides phylum was significantly increased in both the INS and OUTS fecal libraries compared to the mucosa-adherent ileal libraries. Values are expressed as means ± SEM (N = 4).
Major phylogenetic distribution of 16S rRNA gene sequences and phylotypes from treatment groups.
| Phylum | Bacterial taxa | IN | OUT | IR | INS | OUTS |
|---|---|---|---|---|---|---|
| Prevotellaceae (%) | 2.91 | 0.54 | 18.79 | 10.09 | 4.83 | |
| Bacteroidaceae (%) | 0.40 | 0 | 0.76 | 4.08 | 0 | |
| Porphyromonadaceae (%) | 0 | 0.40 | 0.63 | 3.84 | 8.87 | |
| Pasteurellaceae (%) | 14.78 | 2.17 | 2.55 | 0 | 0 | |
| Enterobacteriaceae (%) | 0.4 | 1.36 | 20.7 | 0.24 | 0 | |
| Pseudomonadaceae (%) | 0 | 0 | 0 | 4.08 | 0 | |
| Moraxellaceae (%) | 0 | 0 | 0.63 | 6.25 | 0 | |
| Helicobacteraceae (%) | 10.46 | 0.4 | 0 | 0 | 0 | |
| Campylobacteraceae (%) | 2.61 | 0 | 0 | 0.48 | 0 | |
| Order Bacillales (%) | 0.2 | 0.2 | 0.12 | 5.28 | 0 | |
| Order Lactobacillales (%) | 18.6 | 81.6 | 3.58 | 14.42 | 49.18 | |
| Lachnospiraceae (%) | 3.52 | 0.95 | 8.95 | 3.84 | 8.87 | |
| Veillonellaceae (%) | 0 | 0.4 | 6.9 | 1.68 | 1.61 | |
| Clostridiaceae (%) | 13.17 | 2.72 | 1.27 | 19.95 | 8.06 | |
| Peptostreptococcaceae (%) | 24.44 | 7.49 | 28.9 | 15.38 | 2.41 | |
| Ruminococcaceae (%) | 0.90 | 0.54 | 6.26 | 6.97 | 7.25 |
Figure 4Abundance of lactobacilli in mucosa-adherent ileal and fecal samples in different housing environments. The Lactobacillaceae family included L. reuteri, L. amylovorous LAB31, L. johnsonii, L. delbrueckii subsp. bulgaricus, L salivarius and L. mucosae. L. reuteri, L. delbrueckii and L. johnsonii were all significantly lower in the IN and IR groups compared to the OUT group. Values are expressed as means ± SEM (N = 4).
Figure 5Significantly affected bacterial clones in the mucosa-adherent ileum of animals in different housing environments. Clostridium beijerinckii NCIMB 8052, as well as uncultured bacterial clone BARB_aaa01f06, BARB_aaa02d03 and HH_aai33h06 were significantly decreased in the OUT library compared to the IN library. Uncultured bacterial clone BARB_aaa01f06 and Clostridium beijerinckii NCIMB 8052 were also significantly decreased in the IR group. Values are expressed as means ± SEM (N = 4).
Figure 6Differentially expressed genes in the ileum of animals housed in different environments. Differentially expressed genes at each time-point are shown for the two treatment comparisons (P < 0.01, -2 ≤ fold change ≥ 2, N = 6). Microbiota differences between the treatment groups were associated with large differences in gene expression in the ileum.
MetaCore pathway analysis of differentially expressed genes of the treatment comparison IR versus OUT.
| Cholesterol Biosynthesis | 5.574E-13 | 15 | 21 |
| Oxidative phosphorylation | 0.00002 | 21 | 99 |
| Vitamin B6 metabolism | 0.00412 | 3 | 5 |
| Cell adhesion_Gap junctions | 0.00536 | 6 | 22 |
| Regulation of lipid metabolism_Insulin regulation of fatty acid methabolism | 0.00770 | 9 | 46 |
| Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP | 0.00820 | 7 | 31 |
| Cytoskeleton remodeling_Neurofilaments | 0.01043 | 6 | 25 |
| Ubiquinone metabolism | 0.01169 | 9 | 49 |
| Immune response_Antigen presentation by MHC class I | 0.0127 | 6 | 26 |
| Cell adhesion_Endothelial cell contacts by junctional mechanisms | 0.0127 | 6 | 26 |
| Cholesterol Biosynthesis | 0.00000 | 10 | 21 |
| Immune response_Antigen presentation by MHC class I | 0.00001 | 10 | 26 |
| Immune response_Classic complement pathway | 0.00003 | 12 | 40 |
| Immune response_IFN alpha/beta signalling pathway | 0.00005 | 9 | 24 |
| Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP | 0.00209 | 8 | 31 |
| Immune response_Antiviral actions of Interferons | 0.00209 | 8 | 31 |
| CFTR folding and maturation (norm and CF) | 0.00320 | 5 | 14 |
| Immune response_IL-22 signalling pathway | 0.00321 | 8 | 33 |
| Neurodisease_Parkin disorder under Parkinson's disease | 0.00592 | 7 | 29 |
| Immune response_Antigen presentation by MHC class II | 0.00790 | 4 | 11 |
| Immune response_NFAT in immune response | 0.00027 | 15 | 42 |
| Immune response_Bacterial infections in normal airways | 0.00040 | 14 | 39 |
| Bacterial infections in CF airways | 0.00048 | 15 | 44 |
| Immune response_IL-12-induced IFN-gamma production | 0.00066 | 12 | 32 |
| Immune response_ICOS pathway in T-helper cell | 0.00082 | 13 | 37 |
| Immune response_CD28 signalling | 0.00123 | 14 | 43 |
| Cell adhesion_Integrin-mediated cell adhesion and migration | 0.00201 | 14 | 45 |
| Development_Angiopoietin - Tie2 signalling | 0.00250 | 11 | 32 |
| Apoptosis and survival_HTR1A signalling | 0.00362 | 12 | 38 |
| Sphingolipid metabolism/Human version | 0.00362 | 12 | 38 |
Differentially expressed genes (P < 0.05) were imported into GeneGo MetaCore analytical software to determine the significantly enriched canonical pathways in the treatment comparison IR vs OUT. The top ten pathways for each comparison are shown, with the number of genes assigned to each pathway, and the corresponding P-value.
* The number of genes on each map that are differentially expressed in the specific treatment comparison
** The total number of genes on each map
Figure 7MetaCore pathway analysis of differentially expressed genes of animals housed in different environments. Differentially expressed genes (P < 0.05) were imported into GeneGo MetaCore analytical software to determine significantly enriched canonical pathways in each group. Data represent the distribution in cell process categories of statistically significantly enriched pathways (P < 0.05) of the comparisons IR vs OUT (A) and IN vs OUT (B). Most pathways from both comparisons group into five categories: G-proteins; G-protein coupled receptor; congenital, hereditary and neonatal diseases and abnormalities; immune response; and development. Note that there is redundancy in category allocation.
GO analysis of differentially expressed genes of animals housed in different environments.
| IR vs OUT | IN vs OUT | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GO Category | GO Term | Day 5 | Day 28 | Day 56 | Day 5 | Day 28 | Day 56 | ||||||
| Genes* | Genes* | Genes* | Genes* | Genes* | Genes* | ||||||||
| GO:0019882 | Antigen processing and presentation | 62 | 2.4E-33 | 28 | 8.0E-06 | 26 | 5.1E-05 | 25 | 6.0E-10 | 26 | 1.8E-07 | 26 | 8.8E-06 |
| GO:0002376 | Immune system process | 65 | 3.5E-21 | 42 | 4.3E-07 | 33 | 0.001 | 27 | 1.6E-06 | 30 | 5.4E-05 | 35 | 2.7E-05 |
| GO:0002474 | Antigen processing and presentation of peptide antigen via MHC class I | 15 | 1.6E-08 | 16 | 8.6E-10 | 15 | 7.8E-09 | 14 | 3.0E-11 | 15 | 1.5E-10 | 15 | 2.2E-09 |
| GO:0048002 | Antigen processing and presentation of peptide antigen | 15 | 1.6E-08 | 16 | 8.6E-10 | 15 | 7.8E-09 | 14 | 3.0E-11 | 15 | 1.5E-10 | 15 | 2.2E-09 |
| GO:0006955 | Immune response | 54 | 1.8E-16 | 31 | 4.7E-04 | 16 | 0.021 | 24 | 0.015 | ||||
| GO:0002504 | Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 36 | 1.5E-17 | ||||||||||
| GO:0050896 | Response to stimulus | 57 | 3.5E-07 | 41 | 0.018 | ||||||||
| GO:0006412 | Translation | 13 | 0.002 | ||||||||||
| GO:0006807 | Nitrogen compound metabolic process | 9 | 0.007 | 8 | 0.021 | ||||||||
| GO:0030163 | Protein catabolic process | 5 | 0.008 | ||||||||||
Differentially expressed transcripts (P < 0.05) are shown assigned to the GO-category 'Biological Process'. The top ten GO-categories are shown. The number of transcripts for each function is shown, with the corresponding P-value.
*Genes involved in the specific GO-category
MetaCore pathway analysis of differentially expressed genes of the treatment comparison IN versus OUT.
| Day 5 IN vs OUT | Significant* | Total** | |
|---|---|---|---|
| Transcription_Ligand-Dependent Transcription of Retinoid-Target genes | 0.00022 | 7 | 32 |
| G-protein signalling_G-Protein alpha-s signalling cascades | 0.00473 | 5 | 28 |
| Transcription_CREM signalling in testis | 0.00626 | 4 | 19 |
| Proteolysis_Putative ubiquitin pathway | 0.01076 | 4 | 22 |
| Immune response_PGE2 signalling in immune response | 0.01102 | 5 | 34 |
| Development_Lipoxin inhibitory action on PDGF, EGF and LTD4 signalling | 0.01468 | 4 | 24 |
| Inhibitory action of Lipoxin A4 on PDGF, EGF and LTD4 signalling | 0.01468 | 4 | 24 |
| Cell cycle_Initiation of mitosis | 0.01694 | 4 | 25 |
| Cell cycle_Regulation of G1/S transition (part 1) | 0.01748 | 5 | 38 |
| Muscle contraction_GPCRs in the regulation of smooth muscle tone | 0.02082 | 6 | 54 |
| Cytoskeleton remodeling_CDC42 in cellular processes | 0.00013 | 7 | 22 |
| Oxidative stress_Role of ASK1 under oxidative stress | 0.00013 | 7 | 22 |
| Immune response_Histamine H1 receptor signalling in immune response | 0.00028 | 9 | 40 |
| Development_VEGF signalling and activation | 0.00044 | 8 | 34 |
| Cytoskeleton remodeling_TGF, WNT and cytoskeletal remodeling | 0.00079 | 15 | 107 |
| Cytoskeleton remodeling_Cytoskeleton remodeling | 0.00079 | 14 | 96 |
| Immune response_IL-3 activation and signalling pathway | 0.00108 | 7 | 30 |
| Immune response_Histamine signalling in dendritic cells | 0.00118 | 8 | 39 |
| Development_TGF-beta receptor signalling | 0.00135 | 9 | 49 |
| Signal transduction_Activation of PKC via G-Protein coupled receptor | 0.00267 | 8 | 44 |
| Peroxisomal branched chain fatty acid oxidation | 0.00004 | 8 | 22 |
| Cholesterol Biosynthesis | 0.00024 | 7 | 21 |
| Neurophysiological process_Dopamine D2 receptor transactivation of PDGFR in CNS | 0.00068 | 6 | 18 |
| Propionate metabolism p.1 | 0.00196 | 5 | 15 |
| Development_Angiotensin signalling via beta-Arrestin | 0.00281 | 6 | 23 |
| G-protein signalling_G-Protein alpha-12 signalling pathway | 0.00448 | 7 | 33 |
| Delta508-CFTR traffic/ER-to-Golgi in CF | 0.00783 | 4 | 13 |
| G-protein signalling_Rap2B regulation pathway | 0.00783 | 3 | 7 |
| Development_Mu-type opioid receptor signalling via Beta-arrestin | 0.00962 | 5 | 21 |
| Mitochondrial unsaturated fatty acid beta-oxidation | 0.01709 | 4 | 16 |
Differentially expressed genes (P < 0.05) were imported into GeneGo MetaCore analytical software to determine the significantly enriched canonical pathways in the treatment comparison IN vs OUT. The top ten pathways for each comparison are shown, with the number of genes assigned to each pathway, and the corresponding P-value.
* The number of genes on each map that are differentially expressed in the specific treatment comparison
** The total number of genes on each map
Figure 8Scatterplot of concurrence between Affymetrix microarray data and Real-time PCR data. Correlation between mean fold change values of both comparisons obtained by Affymetrix microarray analysis and Real-time PCR analysis. The diagonal line represents the power trendline (R2 = 0.8405).
Verification of microarray results by Real-time PCR.
| Real time PCR IR vs OUT | Affymetrix microarray | |||||||
|---|---|---|---|---|---|---|---|---|
| Gene | Day | IR* | OUT* | SED** | Fold Change | Fold Change | ||
| 5 | 5.56 ± 0.76 | 4.77 ± 0.72 | 0.42 | -1.73 | 0.092 | -1.56 | 0.014 | |
| 5 | 6.12 ± 1.43 | 7.70 ± 1.04 | 0.72 | 2.99 | 0.056 | 5.00 | 0.003 | |
| 5 | 5.62 ± 2.97 | 8.75 ± 1.54 | 1.37 | 8.71 | 0.054 | 8.28 | 0.008 | |
| 5 | 2.31 ± 3.61 | 7.78 ± 1.88 | 1.66 | 44.33 | 0.012 | 28.70 | 0.002 | |
| 5 | 6.20 ± 2.35 | 8.08 ± 0.45 | 0.98 | 3.66 | 0.110 | 4.67 | 0.017 | |
| 5 | 9.30 ± 1.13 | 8.39 ± 0.38 | 0.49 | -1.88 | 0.111 | -3.19 | 0.005 | |
| 5 | 5.85 ± 1.51 | 7.59 ± 1.44 | 0.85 | 3.34 | 0.069 | 5.69 | 0.044 | |
| 28 | 8.28 ± 0.87 | 10.29 ± 1.29 | 0.68 | 4.04 | 0.021 | 4.41 | 0.000 | |
| 28 | 4.44 ± 0.23 | 5.15 ± 0.27 | 0.14 | 1.63 | 0.001 | 1.83 | 0.003 | |
| 28 | 4.91 ± 1.30 | 7.37 ± 2.36 | 1.10 | 5.52 | 0.057 | 6.28 | 0.007 | |
| 28 | 5.21 ± 1.55 | 6.20 ± 0.70 | 0.69 | 1.99 | 0.196 | 3.56 | 0.006 | |
| 28 | 3.33 ± 2.10 | 6.58 ± 1.58 | 1.07 | 9.49 | 0.014 | 13.01 | 0.001 | |
| 28 | 9.75 ± 0.66 | 7.61 ± 0.78 | 0.42 | -4.43 | 0.000 | -11.62 | 0.000 | |
| 28 | 5.14 ± 1.12 | 7.27 ± 2.04 | 0.95 | 4.38 | 0.056 | 6.34 | 0.001 | |
| 28 | 5.78 ± 1.38 | 7.62 ± 0.89 | 0.67 | 3.58 | 0.024 | 6.88 | 0.000 | |
| 56 | 8.73 ± 0.54 | 7.55 ± 0.42 | 0.28 | -2.27 | 0.002 | -3.82 | 0.007 | |
| 56 | 18.82 ± 0.88 | 16.10 ± 3.29 | 1.39 | -6.60 | 0.101 | -4.03 | 0.003 | |
| 5 | 9.15 ± 0.64 | 7.78 ± 1.20 | 0.56 | -2.58 | 0.041 | -5.01 | 0.005 | |
| 28 | 9.09 ± 1.01 | 8.17 ± 1.18 | 0.63 | -1.89 | 0.177 | 3.91 | 0.010 | |
| 56 | 8.61 ± 0.74 | 9.75 ± 0.95 | 0.49 | 2.20 | 0.044 | 2.64 | 0.025 | |
| 56 | 9.19 ± 0.80 | 10.44 ± 1.31 | 0.63 | 2.38 | 0.080 | 2.44 | 0.009 | |
| 56 | 5.67 ± 1.26 | 9.16 ± 1.28 | 0.82 | 11.17 | 0.004 | 6.80 | 0.002 | |
| 56 | 5.63 ± 2.12 | 7.72 ± 1.79 | 1.13 | 4.26 | 0.095 | 8.32 | 0.009 | |
| 56 | 6.68 ± 0.25 | 7.55 ± 0.42 | 0.20 | 1.83 | 0.002 | 1.75 | 0.008 | |
| 56 | 6.30 ± 0.92 | 7.40 ± 0.93 | 0.53 | 2.15 | 0.065 | 2.90 | 0.011 | |
Real-time PCR results at each time-point for the comparisons IR vs OUT and IN vs OUT.
*PCR values are expressed as mean ΔCt ± SD, N = 6.
**Standard error of difference